SCHEMBL19476161

SCHEMBL19476161

Cc1cc(C)c(NC(=O)c2cc3ccccc3[nH]2)c(C)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.62
RAB9A P51151 3/20 0.62
LMNA P02545 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
EGFR P00533 7/20 0.58
PIK3CA P42336 7/20 0.58
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 1/20 0.57
GAA P10253 1/20 0.57
MAPK1 P28482 1/20 0.57
TP53 P04637 1/20 0.56
POLB P06746 1/20 0.56
PDGFRB P09619 1/20 0.54
PDGFRA P16234 1/20 0.54
IDO1 P14902 1/20 0.53
MAPK8 P45983 1/20 0.53
FLT3 P36888 1/20 0.53
DRD2 P14416 1/20 0.52
DRD3 P35462 1/20 0.52
MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19476086 0.90 NPC1 (0.64) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL19476092 0.89 NPC1 (0.59) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL27337170 0.84 NPC1 (0.73) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL19476095 0.82 NPC1 (0.58) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL19476163 0.81 NPC1 (0.78) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL19476162 0.81 NPC1 (0.64) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL19476085 0.79 TP53 (0.69) NPC1RAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL12764054 0.79 EGFR (0.74) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL19476078 0.79 NPC1 (0.61) NPC1RAB9ALMNASMN1; SMN2EGFR
SCHEMBL3434012 0.78 NPC1 (0.56) NPC1RAB9ALMNASMN1; SMN2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute CE PHARM CO., LTD. (CN) 2020-09-01 US disclosed
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE CE PHARM CO., LTD. (CN) 2019-05-02 US disclosed
EP-3444031-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) 2019-02-20 EP disclosed
WO-2017177979-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE 中国科学院上海有机化学研究所 2017-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE AOC1, AOC2, AOC3 NPC1 3545/4885RAB9A 2403/4885LMNA 4664/4885
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute AOC1, AOC2, AOC3 NPC1 3545/4885RAB9A 2403/4885LMNA 4664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.